Stocks · News reference

8-K filing — BioCardia, Inc. (BCDA)

Aug 24, 2026, 12:30 PMSEC EDGAR

Filed: 2026-08-24 AccNo: 0001437749-26-028778 Size: 178 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

More stocks news Connected markets

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source: edgar
Observed: Aug 24, 2026, 12:30 PM
Checked: Aug 24, 2026, 12:30 PM
Cadence: Captured once, then retained as an archive reference
Status: fresh

Keep reading

BenzingaAug 24, 2026, 12:31 PMBenzinga Newsdesk
BioCardia Says FDA Finalized Pre-Submission Meeting Minutes For Helix Transendocardial Delivery Catheter; Plans Follow-On Pre-Submission This Quarter Toward Potential De Novo Approval
BCDA
BenzingaAug 12, 2026, 8:06 PMBenzinga Newsdesk
BioCardia Q2 EPS $(0.13) Beats $(0.18) Estimate
BioCardia (NASDAQ:BCDA) reported quarterly losses of $(0.13) per share which beat the analyst consensus estimate of $(0.18) by 27.78 percent. This is a 67.5 percent increase over losses of $(0.40) per share from the
BCDA
BenzingaJun 18, 2026, 12:11 PMBenzinga Newsdesk
BioCardia CEO Issued Shareholder Letter To Provide Update; Milestone Includes Submission For Japan's Pharmaceutical and Medical Device Agency Approval Planned For End Of 2026; Driving To Enroll Confirmatory CardiAMP HF II Trial In US
BCDA